2025-05-02 01:05:03
Latest Post
Godrej Agrovet Limited consolidated Q4FY25 net profit drops QoQ to Rs. 70.78 crores
L G Balakrishnan & Bros Ltd posts Rs. 84.03 crores consolidated profit in Q4FY25
Swastika Investmart Ltd Q4 FY2025 consolidated profit slumps to Rs. 27.17 lakhs
Vertex Securities Ltd consolidated Q4 FY25 loss at Rs. 53.99 lakhs
The Federal Bank Limited consolidated Q4FY25 PAT jumps to Rs. 1108.31 crores
Stock Report
Torrent Pharmaceuticals Ltd Q3FY25 consolidated profit climbs to Rs. 503 crores
Posted On : 2025-01-27 20:29:24( TIMEZONE : IST )
Torrent Pharmaceuticals Limited has reported Consolidated financial results for the period ended December 31, 2024.
Financial Results (Q3 FY2025) - QoQ Comparison
The company has reported total income of Rs. 2842 crores during the period ended December 31, 2024 as compared to Rs. 2873 crores during the period ended September 30, 2024.
The company has posted net profit / (loss) of Rs. 503 crores for the period ended December 31, 2024 as against net profit / (loss) of Rs. 453 crores for the period ended September 30, 2024.
The company has reported EPS of Rs. 14.88 for the period ended December 31, 2024 as compared to Rs. 13.37 for the period ended September 30, 2024.
| Financials | Q3 FY2025 | Q2 FY2025 | % Change |
| Total Income | ₹ 2842 crs | ₹2873 crs |  -1.08% |
| Net Profit | ₹503 crs | ₹453 crs |  11.04% |
| EPS | ₹14.88 | ₹13.37 | 11.29% |
Financial Results (Q3 FY2025) - YoY Comparison
The company has reported total income of Rs. 2842 crores during the period ended December 31, 2024 as compared to Rs.2699 crores during the period ended December 31, 2023.
The company has posted net profit / (loss) of Rs.503 crores for the period ended December 31, 2024 as against net profit / (loss) of Rs.443 crores for the period ended December 31, 2023.
The company has reported EPS of Rs.14.88 for the period ended December 31, 2024 as compared to Rs.13.10 for the period ended December 31, 2023.
| Financials | Q3 FY2025 | Q3 FY2024 | % Change |
| Total Income | ₹ 2842 crs | ₹2699 crs | 5.30% |
| Net Profit | ₹503 crs | ₹443 crs | 13.54% |
| EPS | ₹14.88 | ₹13.10 | 13.59% |
Financial Results (9 Months Ended FY2025) - YoY Comparison
The company has reported total income of Rs.8598 crores during the 9 Months period ended December 31, 2024 as compared to Rs.8010 crores during the 9 Months period ended December 31, 2023.
The company has posted net profit / (loss) of Rs.1413 crores for the 9 Months period ended December 31, 2024 as against net profit / (loss) of Rs.1207 crores for the 9 Months period ended December 31, 2023.
The company has reported EPS of Rs.41.76 for the 9 Months period ended December 31, 2024 as compared to Rs.35.67 for the 9 Months period ended December 31, 2023.
| Financials | 9 Months Ended FY2025 | 9 Months Ended FY2024 | % Change |
| Total Income | ₹8598 crs | ₹8010 crs | 7.34% |
| Net Profit | ₹1413 crs | ₹1207 crs | 17.07% |
| EPS | ₹41.76 | ₹35.67 | 17.07% |
Shares of Torrent Pharmaceuticals Limited was last trading in BSE at Rs. 3247.75 as compared to the previous close of Rs. 3266.20. The total number of shares traded during the day was 2356 in over 659 trades.
The stock hit an intraday high of Rs. 3266.00 and intraday low of 3213.05. The net turnover during the day was Rs. 7636281.00.
